The company
Alnylam Pharmaceuticals, Inc.
ALNY · Nasdaq
Health CareBiotechnologyNot moving yet
ALNY stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 45 weeks. It is 16.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 45
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $70.4M
- Officials’ trades on record
- 28
- Institutions holding
- 745 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.
17 Apr – 16 Oct
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars.
Congress and officials
28 disclosed lines: House 17, Senate 1, executive 10; 7 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 28 Aug 2026filed 8 Oct 2026 |
| Cory A. Booker Senate: U.S. Senate eFDSenator | soldspouse | $1k–$15k | 11 Aug 2026filed 9 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 10 Aug 2026filed 8 Oct 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 17 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 16 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 7 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 23 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 19 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 23 Jan 2026filed 14 May 2026 |
| Jefferson Shreve House: U.S. House ClerkIN06 | sold | $15k–$50k | 12 May 2025filed 22 Jun 2025 |
Insiders
Buy orders, 12 months0
Sale orders, 12 months34
Buyers · sellers0 · 8
| Who | Did | Shares | Traded |
|---|---|---|---|
| Bryan SupranEVP, CLO and Secretary | sold | 1,758at $226.88 | 2 Oct 2026filed 6 Oct 2026 |
| David E. I. PyottDirector | sold | 921at $297.71 | 1 Jun 2026filed 3 Jun 2026 |
| David E. I. PyottDirector | sold | 1,175at $298.91 | 1 Jun 2026filed 3 Jun 2026 |
| David E. I. PyottDirector | sold | 1,222at $299.87 | 1 Jun 2026filed 3 Jun 2026 |
| David E. I. PyottDirector | sold | 495at $300.72 | 1 Jun 2026filed 3 Jun 2026 |
| David E. I. PyottDirector | sold | 17at $302.65 | 1 Jun 2026filed 3 Jun 2026 |
| Melissa McLaughlinChief Human Resources Officer | sold | 56at $320.14 | 6 Apr 2026filed 7 Apr 2026 |
| Melissa McLaughlinChief Human Resources Officer | sold | 909at $329.76 | 6 Apr 2026filed 7 Apr 2026 |
| Melissa McLaughlinChief Human Resources Officer | sold | 829at $330.46 | 6 Apr 2026filed 7 Apr 2026 |
| Melissa McLaughlinChief Human Resources Officer | sold | 293at $331.89 | 6 Apr 2026filed 7 Apr 2026 |
| Melissa McLaughlinChief Human Resources Officer | sold | 199at $333.94 | 6 Apr 2026filed 7 Apr 2026 |
| Melissa McLaughlinChief Human Resources Officer | sold | 265at $316.61 | 2 Apr 2026filed 7 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Holders745-3 on the quarter
New · exited87 · 90
Reported value$38.0B
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 15,023,962$4.5B | +444,796+3.1% |
| Capital World Investorsadded · filed 12 Aug 2026 | 11,144,846$3.4B | +342,498+3.2% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 10,907,675$3.3B | +462,767+4.4% |
| Capital Research Global Investorsadded · filed 12 Aug 2026 | 9,750,699$2.9B | +279,518+3.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,538,390$2.0B | +47,110+0.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,029,478$1.8B | +82,772+1.4% |
| Invesco Ltd.added · filed 14 Aug 2026 | 3,754,318$1.1B | +2,462,592+190.6% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,555,689$1.1B | +232,991+7.0% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 2,675,517$785.3M | +2,675,517 |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 2,635,840$791.3M | -24,545−0.9% |
31 Mar 2023 – 30 Jun 2026
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.